Ubiquitination of protein kinase C-alpha and degradation by the proteasome - PubMed (original) (raw)
. 1996 Aug 30;271(35):20973-6.
Affiliations
- PMID: 8702857
Free article
Ubiquitination of protein kinase C-alpha and degradation by the proteasome
H W Lee et al. J Biol Chem. 1996.
Free article
Abstract
Bryostatins and phorbol esters acutely activate and subsequently down-regulate protein kinase C (PKC) by inducing its proteolysis via an unknown pathway. Here we show that treatment of renal epithelial cells with bryostatin 1 (Bryo) produced novel PKC-alpha species, which were larger than the native protein (80 kDa). The >80 kDa PKC-alpha species contained Ubi as indicated by immunostaining and accumulated in the presence of lactacystin, a selective inhibitor of proteolysis by the proteasome. In vitro experiments with 125I-ubiquitin and membranes from Bryo-treated cells showed that PKC-alpha became ubiquitinated by a reaction that depended on ATP and a cytosolic fraction. Lactacystin or a peptidyl aldehyde, Bz-Gly-Leu-Ala-leucinal, which inhibits certain proteinase activities of the proteasome, inhibited Bryo-evoked disappearance of PKC-alpha protein from the cells. Lacta preserved Bryo-induced 32P-labeled PKC-alpha indicating that the proteasome inhibitor spared activated enzyme from down-regulation in vivo. These findings show that Bryo induces the degradation of PKC-alpha by the ubiquitin-proteasome complex.
Similar articles
- Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh.
Wall NR, Mohammad RM, Reddy KB, Al-Katib AM. Wall NR, et al. Int J Mol Med. 2000 Feb;5(2):165-71. doi: 10.3892/ijmm.5.2.165. Int J Mol Med. 2000. PMID: 10639596 - The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha.
Clarke H, Ginanni N, Laughlin KV, Smith JB, Pettit GR, Mullin JM. Clarke H, et al. Exp Cell Res. 2000 Nov 25;261(1):239-49. doi: 10.1006/excr.2000.5035. Exp Cell Res. 2000. PMID: 11082294 - Lactacystin, proteasome function, and cell fate.
Fenteany G, Schreiber SL. Fenteany G, et al. J Biol Chem. 1998 Apr 10;273(15):8545-8. doi: 10.1074/jbc.273.15.8545. J Biol Chem. 1998. PMID: 9535824 Review. No abstract available.
Cited by
- Protein Kinase C Life Cycle: Explained Through Systems Biology Approach.
Aslam N, Alvi F. Aslam N, et al. Front Physiol. 2022 Apr 14;13:818688. doi: 10.3389/fphys.2022.818688. eCollection 2022. Front Physiol. 2022. PMID: 35492590 Free PMC article. - Targeting Protein Kinase C for Cancer Therapy.
He S, Li Q, Huang Q, Cheng J. He S, et al. Cancers (Basel). 2022 Feb 22;14(5):1104. doi: 10.3390/cancers14051104. Cancers (Basel). 2022. PMID: 35267413 Free PMC article. Review. - Protein Kinase C-α Is a Gatekeeper of Cryptosporidium Sporozoite Adherence and Invasion.
McCowin S, Petri WA Jr, Marie C. McCowin S, et al. Infect Immun. 2022 Mar 17;90(3):e0067921. doi: 10.1128/iai.00679-21. Epub 2022 Jan 18. Infect Immun. 2022. PMID: 35099276 Free PMC article. - TRAF2 Is a Novel Ubiquitin E3 Ligase for the Na,K-ATPase β-Subunit That Drives Alveolar Epithelial Dysfunction in Hypercapnia.
Gabrielli NM, Mazzocchi LC, Kryvenko V, Tello K, Herold S, Morty RE, Grimminger F, Dada LA, Seeger W, Sznajder JI, Vadász I. Gabrielli NM, et al. Front Cell Dev Biol. 2021 Jul 2;9:689983. doi: 10.3389/fcell.2021.689983. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34277634 Free PMC article. - PHLPPing the balance: restoration of protein kinase C in cancer.
Tovell H, Newton AC. Tovell H, et al. Biochem J. 2021 Jan 29;478(2):341-355. doi: 10.1042/BCJ20190765. Biochem J. 2021. PMID: 33502516 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources